[vc_section][vc_row max_width=”80″ wpex_bg_overlay=”custom” css=”.vc_custom_1632902121546{background-image: url(https://www.predilife.com/wp-content/uploads/2021/09/entete-accueil.webp?id=2986) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” wpex_bg_position=”top left”][vc_column][vc_empty_space height=”120px”][vc_row_inner][vc_column_inner width=”1/2″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]

Predilife
The company

[/vc_column_text][vc_empty_space height=”40px”][vc_column_text el_class=”stroke stroke-blanc”]See the interview with Stéphane Ragusa, CEO of Predilife[/vc_column_text][vc_empty_space height=”180px”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row css=”.vc_custom_1632145116081{background-color: #ffffff !important;}” el_class=”rangee-negative”][vc_column][vc_empty_space height=”40px” el_class=”marge-mobile”][vc_row_inner][vc_column_inner][vc_column_text]

The company

[/vc_column_text][vc_empty_space height=”30px”][vc_column_text]

Founded in 2004 by Stéphane Ragusa, Predilife has pioneered the design and development of prediction tests, giving everyone the chance to find out their own risk of developing serious diseases. It combines proven medical techniques with Artificial Intelligence and Big Data.

Predilife is a company at the heart of predictive medicine. Predictive medicine involves anticipating an individual’s future so that action can be taken in time thanks to personalised prevention, either by reducing risk, or by identifying the disease as early as possible. Serious conditions, such as cancer and heart attack, can be better prevented.

Since 2018, Predilife has been listed on Euronext.

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_empty_space height=”20px”][vc_empty_space height=”60px”][/vc_column][/vc_row][/vc_section][vc_row max_width=”70″ el_class=”z-index-positif”][vc_column][vc_row_inner][vc_column_inner width=”2/3″][vc_column_text text_align=”left”]

Our vision

[/vc_column_text][vc_empty_space height=”30px”][vc_column_text]« The sooner the better ».

Stéphane Ragusa, CEO of Predilife, is a graduate of the prestigious École Polytechnique engineering school. For several years, he has implemented many innovations in the field of predictive and preventive medicine to enable men and women to anticipate their risk of developing serious diseases, and consequently to take action.[/vc_column_text][vc_empty_space height=”40px” el_class=”marge-mobile”][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”3084″ alignment=”right”][vc_empty_space height=”40px” el_class=”marge-mobile”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row max_width=”70″ css=”.vc_custom_1632234828940{background-color: #f7f7f7 !important;}” el_class=”z-index-negatif”][vc_column][vc_empty_space height=”60px”][vc_row_inner content_placement=”bottom”][vc_column_inner width=”1/3″][vc_single_image image=”3103″ alignment=”right”][vc_empty_space height=”40px” el_class=”marge-mobile”][/vc_column_inner][vc_column_inner width=”2/3″][vc_column_text text_align=”left”]

Our mission

[/vc_column_text][vc_empty_space height=”30px”][vc_column_text text_align=”right”]

Predilife develops predictive tests for the medicine of the future: Predictive, Preventive, Personalised and Participative (the 4 Ps). Predictive medicine involves anticipating an individual’s future so that action can be taken in time thanks to personalised prevention, either by reducing risk (known as primary prevention), or by identifying the disease as early as possible (secondary prevention).

Serious conditions, such as cancer and heart attack, can be better prevented.

Predilife is committed to respecting the General Data Protection Regulation (GDPR) and attaches particular importance to data security and preserving patients’ medical confidentiality..

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_empty_space height=”60px”][/vc_column][/vc_row][vc_row max_width=”70″][vc_column][vc_empty_space height=”60px”][vc_column_text el_class=”stroke-reverse”]

The team

[/vc_column_text][vc_empty_space height=”30px”][vc_column_text]The Predilife Board, comprising Stéphane Ragusa, Élise Tronel, Émilien Gauthier and Marion Renelier, is supported by 5 developers, 8 employees and 8 sales representatives in France and abroad.[/vc_column_text][vc_empty_space height=”50px”][/vc_column][/vc_row][vc_row max_width=”80″][vc_column][vc_row_inner][vc_column_inner width=”1/4″][vc_single_image image=”2972″ alignment=”center”][vc_empty_space height=”20px”][vc_column_text text_align=”center” font_size=”17px” font_weight=”600″]Stéphane Ragusa[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” color=”#1f2d54″ font_size=”24px”]Chief Executive Officer[/vc_column_text][vc_empty_space height=”10px”][vcex_social_links social_links=”%5B%7B%22site%22%3A%22linkedin%22%2C%22link%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2Fst%C3%A9phane-ragusa-3786157%2F%3ForiginalSubdomain%3Dfr%22%7D%5D” bottom_margin=”0px” link_target=”_blank” style=”none” align=”center” color=”#192a56″ hover_color=”#ffffff” hover_bg=”#32d6f8″][vc_empty_space height=”40px”][/vc_column_inner][vc_column_inner width=”1/4″][vc_single_image image=”4322″ alignment=”center”][vc_empty_space height=”20px”][vc_column_text text_align=”center” font_size=”17px” font_weight=”600″]Élise Tronel[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” color=”#1f2d54″ font_size=”24px”]Sales director[/vc_column_text][vc_empty_space height=”10px”][vcex_social_links social_links=”%5B%7B%22site%22%3A%22linkedin%22%2C%22link%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2Fvotrefuturedirectice%2F%3ForiginalSubdomain%3Dfr%22%7D%5D” bottom_margin=”0px” link_target=”_blank” style=”none” align=”center” color=”#192a56″ hover_color=”#ffffff” hover_bg=”#32d6f8″][vc_empty_space height=”40px”][/vc_column_inner][vc_column_inner width=”1/4″][vc_single_image image=”2716″ alignment=”center”][vc_empty_space height=”20px”][vc_column_text text_align=”center” font_size=”17px” font_weight=”600″]Émilien Gauthier[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” color=”#1f2d54″ font_size=”24px”]Chief Technology Officer[/vc_column_text][vc_empty_space height=”10px”][vcex_social_links social_links=”%5B%7B%22site%22%3A%22linkedin%22%2C%22link%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2F%C3%A9milien-gauthier-cto%2F%3ForiginalSubdomain%3Dfr%22%7D%5D” bottom_margin=”0px” link_target=”_blank” style=”none” align=”center” color=”#192a56″ hover_color=”#ffffff” hover_bg=”#32d6f8″][vc_empty_space height=”40px”][/vc_column_inner][vc_column_inner width=”1/4″][vc_single_image image=”2974″ alignment=”center”][vc_empty_space height=”20px”][vc_column_text text_align=”center” font_size=”17px” font_weight=”600″]Marion Renelier[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” color=”#1f2d54″ font_size=”24px”]Legal Director[/vc_column_text][vc_empty_space height=”10px”][vcex_social_links social_links=”%5B%7B%22site%22%3A%22linkedin%22%2C%22link%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2Fmarion-renelier-063868123%2F%3ForiginalSubdomain%3Dfr%22%7D%5D” bottom_margin=”0px” link_target=”_blank” style=”none” align=”center” color=”#192a56″ hover_color=”#ffffff” hover_bg=”#32d6f8″][vc_empty_space height=”40px”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row max_width=”70″][vc_column][vc_empty_space height=”20px”][vc_column_text el_class=”titre-reverse”]

The history of Predilife

[/vc_column_text][vc_empty_space height=”60px”][/vc_column][/vc_row][vc_section el_class=”container-slider”][vc_row max_width=”80″ el_class=”slider”][vc_column el_id=”test”][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2004[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]Predilife founded
by Stéphane Ragusa[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2007[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]Contract with INSERM for access to their cohorts of data[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2013[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]Contract with BCSC (Breast Cancer Surveillance Consortium) for access to their database on 1,000,000 American women.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2017[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]First FDA agreement obtained for DenSeeMammo

Riviera study (NCT02997384) sponsored by Gustave Roussy and funded by ARC (Association for Cancer Research), aiming to show the acceptability and feasibility of breast cancer risk consultations in community practice.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2018[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]Predilife goes public. CE marking for MammoRisk and DenSeeMammo.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2019[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]The MyPeBS study is launched.
Access to the French and European market.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2020[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]Deployment of a sales team in France and Europe.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”slide vc_col-sm-3″][vc_column_inner][vc_empty_space height=”60px” el_class=”hexagone”][vc_column_text text_align=”center” font_size=”18px” font_weight=”700″ line_height=”0.8″]2021[/vc_column_text][vc_empty_space height=”10px”][vc_column_text text_align=”center” font_size=”14px”]CE marking of risk prediction medical devices for cancers: prostate, colon, lung and for heart attack[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”fleches”][vc_column][vc_raw_html]JTNDYSUyMGhyZWYlM0QlMjIlMjNzbGlkZSUyMiUyMGlkJTNEJTIyYmFjayUyMiUzRXRlc3QlM0MlMkZhJTNFJTBBJTNDYSUyMGhyZWYlM0QlMjIlMjNzbGlkZSUyMiUyMGlkJTNEJTIyZm9yd2FyZCUyMiUzRXRlc3QlM0MlMkZhJTNF[/vc_raw_html][/vc_column][/vc_row][/vc_section][vc_row][vc_column][vc_empty_space height=”30px”][/vc_column][/vc_row][vc_section el_class=”fond-gris”][vc_row css=”.vc_custom_1632145116081{background-color: #ffffff !important;}” el_class=”rangee-negative”][vc_column][vc_empty_space height=”40px”][vc_row_inner css=”.vc_custom_1632229781749{background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_inner][vc_single_image image=”2724″ onclick=”custom_link” img_link_target=”_blank” link=”https://www.predilife.com/wp-content/uploads/2021/06/Presentation-PREDILIFE.pdf” css=”.vc_custom_1632308239598{padding-right: 0px !important;padding-left: 0px !important;}”][/vc_column_inner][/vc_row_inner][vc_empty_space height=”60px”][vc_row_inner][vc_column_inner][vc_column_text text_align=”right” el_class=”titre-reverse”]

Our historical partners

[/vc_column_text][vc_empty_space height=”50px”][vcex_image_carousel thumbnail_link=”custom_link” arrows_position=”abs” image_ids=”2943,2942,2941,2844″ img_height=”80px” custom_links=”https://www.pantheonsorbonne.fr/accueil,https://curie.fr/,https://www.inserm.fr/,https://www.gustaveroussy.fr/,” custom_links_target=”self” arrows_style=”slim”][vc_empty_space height=”80px”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][/vc_section]